News

Launch Diagnostics recognised in the Parliamentary Review

Press Release: 12th September 2019 The strategic aim of The Parliamentary Review is to raise standards. In each edition, a host of outstanding organisations share their experiences and areas of […]

Read More

IBMS Congress – 22nd to 25th September

Join us on stand 216 at the IBMS Congress, ICC Birmingham, from 22nd to 25th September 2019  

Read More

Events, Meetings and Conferences

Launch Diagnostics regularly attends Congresses, Exhibitions and Trade Shows where you can learn more about our new products and services. Join us at these upcoming events Date Society Meeting Sunday […]

Read More

ALETHIA™ LAMP based Molecular Solution available from Launch Diagnostics

Alethia™ now represents the Meridian Bioscience molecular solution formerly known as illumigene. It is a rapid, simple to use loop-mediated isothermal amplification (LAMP) based molecular system with a small, dedicated instrument […]

Read More

Serological infectious diseases: a solution that meets a gap in the market

An article by Jamie Laughlin, ‘Serological infectious diseases: a solution that meets a gap in the market’  has been published in the August 2018 edition of Pathology in Practice.  The article […]

Read More

VirClia solution for infectious disease testing

The VirClia® monotest solution for the detection of antibodies to a range of infectious diseases. The system uses an indirect chemiluminescent immunoassay (CLIA) method in a monotest format to test antibodies […]

Read More

Liofilchem Culture Media for AST

Liofilchem offers a range of culture media manufactured to comply with the European Committee on Antimicrobial Susceptibility (EUCAST) guidelines. Recently, the EUCAST guidelines for the determination of antimicrobial susceptibility are […]

Read More

BioGX announces their partnership with Launch Diagnostics

BioGX Press Release dated 08.02.2018: Launch Diagnostics, based in England, is now responsible for the distribution of BioGX B.V. products throughout the U.K., as well as the Republic of Ireland. […]

Read More

NEW VIRCLIA INFECTIOUS DISEASE SEROLOGY ASSAYS AVAILABLE

Vircell has added a number of new assays to their VirClia range, enhancing their extensive portfolio of chemiluminescent monotests for infectious disease serology. New assays include Hepatitis E IgG and […]

Read More

New Glioblastoma Panel

Our partner EntroGen has developed rapid qPCR based assays for Glioblastoma molecular diagnosis, targeting three major molecular markers. Please check out their website (https://entrogen.com/web3/) for more information and our product […]

Read More